Stress-specific response of the p53-Mdm2 feedback loop

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Hunziker, Alexander ^a   Jensen, Mogens H ^a   Krishna, Sandeep ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ARTICLE; BIOLOGICAL MODEL; COMPUTER SIMULATION; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPUTER SIMULATION; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MDM2; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954398160     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-94     Document Type: Article

References (47)

1. Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored?. Cell Death Differ 2006, 13(6):1027-36. 10.1038/sj.cdd.4401910, 16557269.
2. Batchelor E, Loewer A, Lahav G. The ups and downs of p53: understanding protein dynamics in single cells. Nat Rev Cancer 2009, 9:371-377. 10.1038/nrc2604, 2892289, 19360021.
3. Levine AJ. p53, the Cellular Gatekeeper for Growth and Division. Cell 1997, 88:323-331. 10.1016/S0092-8674(00)81871-1, 9039259.
4. Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoff-man W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 2001, 21(4):1297-310. 10.1128/MCB.21.4.1297-1310.2001, 99582, 11158315.
5. Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes & Development 1996, 10(8):934.
6. Sionov RV, Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 1999, 18:6145-6157. 10.1038/sj.onc.1203130, 10557106.
7. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S. Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation. Cell 2003, 112:779-791. 10.1016/S0092-8674(03)00193-4, 12654245.
8. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. The ubiq-uitin ligase COP1 is a critical negative regulator of p53. Nature 2004, 429(6987):86-92. 10.1038/nature02514, 15103385.
9. Barboza JA, Iwakuma T, Terzian T, El-Naggar AK, Lozano G. Mdm2 and Mdm4 loss regulates distinct p53 activities. Mol Cancer Res 2008, 6:947-954. 10.1158/1541-7786.MCR-07-2079, 2699947, 18567799.
10. Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, van Ham RC, van der Houven van Oordt W, Hateboer G, van der Eb AJ, Jochemsen AG. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 1996, 15(19):5349-5357. 452278, 8895579.
11. Montes de Oca Luna R. Rescue of early embrionic lethality in mdm2-deficient mice by deletion of p53. Nature 1995, 378:203-206. 10.1038/378203a0, 7477326.
12. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W. Mono-Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2. Science 2003, 302:1972-1975. 10.1126/science.1091362, 14671306.
13. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005, 24(17):2899. 10.1038/sj.onc.1208615, 15838523.
14. Kaku S, Iwahashi Y, Kuraishi A, Albor A, Yamagishi T, Nakaike S, Kulesz-Martin M. Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation. Nucl Acids Res 2001, 29:1989-1993. 10.1093/nar/29.9.1989, 37263, 11328884.
15. Itahana K, Mao H, Jin A, Itahana Y, Clegg HV, Lind-strom MS, Bhat KP, Godfrey VL, Evan GI, Zhang Y. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 2007, 12:355-366. 10.1016/j.ccr.2007.09.007, 17936560.
16. Tiana G, Sneppen K, Jensen MH. Time delay as a key to apoptosis induction in the p53 network. Euro-phys J B 2002, 29:135-140.
17. Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, Stolovitzky G. A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci (USA) 2005, 102:14266-14271.
18. Wagner J, Ma L, Rice JJ, Hu W, Levine AJ, Stolovitzky G. p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback. IEE Proc-Syst Biol 2005, 152:109-118.
19. Ciliberto A, Novak B, Tyson JJ. Steady states and oscillations in the p53/Mdm2 network. Cell Cycle 2005, 4:488-493.
20. Bacthelor E, Mock CS, Bhan I, Loewer A, Lahav G. Recurrent initiation: A mechanism for triggering p53 pulses in response to DNA damage. Mol Cell 2008, 30:277-289. 10.1016/j.molcel.2008.03.016, 2579769, 18471974.
21. Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Si-gal A, Dekel E, Yarnithky T, Polak P, Liron Y, Kam Z, Lahav G, Alon U. Oscillations and variability in the p53 system. Molecular Systems Biology 2006, 2. 10.1038/msb4100068, 1681500, 16773083.
22. Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996, 10:2438-2451. 10.1101/gad.10.19.2438, 8843196.
23. Inga A, Storici F, Darden TA, Resnick MA. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol Cell Biol 2002, 22:8612-8625. 10.1128/MCB.22.24.8612-8625.2002, 139870, 12446780.
24. Tyson JJ. Another turn for p53. Mol Sys Biol 2006, 2:0032.
25. Krishna S, Jensen MH, Sneppen K. Minimal model of spiky oscillations in NF-kB signalling. Proc Natl Acad Sci (USA) 2006, 103:10840-10845.
26. Lu X, Burbidge SA, Griffn S, Smith HM. Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation. Oncogene 1996, 13:413-418.
27. Bond GL, Hu W, Levine AJ. MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting. Current Cancer Drug Targets 2005, 5:3-8. 10.2174/1568009053332627, 15720184.
28. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004, 303(5659):844-8. 10.1126/science.1092472, 14704432.
29. Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Seminars in Cancer Biology 2003, 13:49-58. 10.1016/S1044-579X(02)00099-8, 12507556.
30. Stommel JM, Wahl GM. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. EMBO J 2004, 23(7):1547-56. 10.1038/sj.emboj.7600145, 391059, 15029243.
31. Hamstra DA, Bhojani MS, Griffn LB, Laxman B, Ross BD, Rehemtulla A. Real-time Evaluation of p53 Oscillatory Behavior In vivo Using Bioluminescent Imaging. Cancer Res 2006, 66:7482-7489. 10.1158/0008-5472.CAN-06-1405, 16885345.
32. Hammond EM, Giaccia AJ. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 2005, 331(3):718-25. 10.1016/j.bbrc.2005.03.154, 15865928.
33. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004, 57(10):1009-14. 10.1136/jcp.2003.015032, 1770458, 15452150.
34. Moll UM, Petrenko O. The MDM2-p53 Interaction. Molecular Cancer Research 2003, 1:1001-1008.
35. Hu W, Feng Z, Ma L, Wagner J, Rice JJ, Stolovitzky G, Levine AJ. A single nucleotide polymorphism in the Mdm2 gene disrupts the oscillation of p53 and Mdm2 levels in cells. Cancer Res 2007, 67(6):2757-2765. 10.1158/0008-5472.CAN-06-2656, 17363597.
36. Harris SL, Gil G, Robins H, Hu W, Hirshfield K, Bond E, Bond G, Levine AJ. Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Natl Acad Sci USA 2005, 102(45):16297-302. 10.1073/pnas.0508390102, 1283473, 16260726.
37. Wang YV, Wade M, Wong E, Li YC, Rodewald LW, Wahl GM. Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation. Proc Natl Acad Sci (USA) 2007, 104:12365-12370.
38. Gillespie DT. Exact Stochastic Simulation of Coupled Chemical Reactions. J Phys Chem 1977, 81:2340-2361.
39. Proctor CJ, Gray DA. Explaining oscillations and variability in the p53-Mdm2 system. BMC Sys Biol 2008, 2:75.
40. Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, Jhappan C, Higashimoto Y, He P, Linke SP, Quezado MM, Zurer I, Rotter V, Wink DA, Appella E, Harris CC. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 2003, 100(1):143-8. 10.1073/pnas.0237083100, 140909, 12518062.
41. King FW, Wawrzynow A, Höhfeld J, Zylicz M. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J 2001, 20(22):6297-6305. 10.1093/emboj/20.22.6297, 125724, 11707401.
42. Nitta M, Okamura H, Aizawa S, Yamaizumi M. Heat shock induces transient p53-dependent cell cycle arrest at G1/S. Oncogene 1997, 15:561-568. 10.1038/sj.onc.1201210, 9247309.
43. Zyclicz M, King FW, Wawrzynow A. Hsp70 interactions with the p53 tumour supporessor protein. EMBO J 2001, 20(17):4634-4638. 10.1093/emboj/20.17.4634, 125613, 11532927.
44. Toettcher JE, Loewer A, Ostheimer GJ, Yaffe MB, Tidor B, Lahav G. Distinct mechanisms act in concert to mediate cell cycle arrest. Proc Natl Acad Sci (USA) 2009, 106:785-790.
45. Pahl HL. Activators and target genes of Rel/NF-kB transcription factors. Oncogene 1999, 18:6853-6866. 10.1038/sj.onc.1203239, 10602461.
46. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkB-NF-kB signaling module: temporal control and selective gene activation. Science 2002, 298:1241-1245. 10.1126/science.1071914, 12424381.
47. Nelson DE, et al. Oscillations in NF-kB signaling control the dynamics of gene expression. Science 2004, 306:704-708. 10.1126/science.1099962, 15499023.